Non-invasive Methods of Measuring Lung Volume

NCT ID: NCT06681467

Last Updated: 2025-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-20

Study Completion Date

2025-05-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Each breath humans take can be split into different measurements that clinicians can use to see how well a patient's lungs are working. Clinicians take these measurements to see how the lungs of patients with conditions such as asthma, chronic obstructive pulmonary disease or other muscle problems are affected. This also allows us to monitor how a patient's disease changes over time. At present, to measure lung volumes patients need to attend a clinic appointment and complete a test called spirometry. This takes both time and effort for patients and not all will be able to attend. There are simple devices available that can be attached to patients which measure breathing parameters such as breathing rate. Many different devices are available to do this; a common version is a chest band. These comprise of a tight-fitting band that is placed around the centre of the chest and as patients breathe in and out, the band stretches and contracts. The force of this stretching and contraction can be measured and turned in to a continuous breathing rate. Although this is useful, there is no device that can currently measure lung volumes as well as spirometry can. Therefore, the investigators will use software analysis to change data collected from two different chest bands to make the measurements comparable to spirometry testing. Doing this could mean that patients could test their breathing at home and any problems be picked up sooner. It would also help patients be more involved in the care of their breathing and may lead to earlier treatments. Our study is the first stage in developing this device, but the investigators hope that it will help with other research later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design was chosen so that the investigators can directly compare results produced from wearable respiratory devices to spirometry. In order to do this in a protocolised manner, pulmonary function testing (PFT) clinic was chosen as the location of the study. Prior to the protocol being agreed, this was discussed and approved by the medical and nursing team in charge of the pulmonary function clinic. The investigators also approached patients in PFT clinic to discuss the proposed protocol and if they felt it was suitable for someone attending the clinic. The investigators received positive responses form this and any comments were considered in the final protocol.

Potential participants will be identified when they are booking into their clinic appointment. All patients will be attending PFT clinic as part of their clinical care; none will be attending as part of the study only. Patients will be asked if they would like to participate in the study after receiving the patient information leaflet and given time to ask any questions. The investigators aim to recruit 50 patients. This was deemed a suitable number to be able to undertake machine learning analysis with sufficient data. The investigators aim to recruit these 50 patients by attending PFT clinic weekly for approximately 3 months. They will vary the days of the week/clinic times they attend to gain a range of different patient groups as PFT clinics vary across the week.

After participants are fully consented, baseline data will be collected. This will involve a medical questionnaire that they will be asked to complete. The following data will be collected using the questionnaire:

Patient demographics: Age, sex, height, weight Comorbidities including past medical and surgical history Smoking status Alcohol status Current medications used Allergy status Reason for spirometry testing

Once the questionnaire is completed the participants will start the measurement section of the study. They will have two respiratory measurement devices attached. The Go Direct Respiration Sensor and a biosignal respiratory belts will both be fitted over light clothing so that participants will wear both sensors at once. They work in different ways but both use chest movement during breathing to determine respiratory effort and respiratory rate. They fit as bands around the chest. The investigators will aim to place the devices in similar positions in all participants (around the centre of the chest at the breast bone). Before confirming their placement, participants will be asked if the devices are comfortable and allow for normal breathing. These devices will track chest movement for the duration of the spirometry test and during timed activities of sitting, speaking, and walking. Once fitted, participants will continue with their spirometry appointment as planned. Some results from their spirometry testing will be noted in a secure database. This will include their inspiratory reserve volume, expiratory reserve volume, tidal volume and forced expiratory volume. The values alone will be recorded with no other patient data from the clinic appointment. At the end of the appointment, once they are back at baseline breathing, participants will be asked to read a short standardised script (in the form of a simple poem) over the course of 1-2 minutes that will allow us to analyse breathing patterns during speech. This will be coordinated with audio recordings of the speech which will be used in later data analysis of speech breathing. This may occur in the clinic room or another quiet room opposite the clinic depending on clinic timings. The final task before removal of the devices will be a short walk down the corridor outside of the clinical room to assess breathing during light exercise. This will be a set distance of 75 meters and should take around 1 minute to complete. Variability in timing of the walk will be accepted due to different patient walking speeds. The total data collection will take approximately 30 minutes. There should not be any additional clinic time required as the speech assessment and walking assessment can be undertaken outside of the clinic room. When the devices are removed, participants will be asked if they wish to comment on anything they felt during the study including discomfort from wearing the devices. The spirometry data will be collected by the PFT team as part of their routine testing and as such should not be influenced by the study. The researcher will not be involved in the spirometry testing portion of the study and therefore should not bias any results obtained.

Once the bands are removed the data will be downloaded onto a secure laptop with all patient identifying information removed. Following the collection of data for all 50 patients, the investigators aim to spend a further 1-2 months analysing the data and comparing it to the spirometry results. The final report will be available within 24 months of the study start date.

There will not be any planned interim analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiration Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing planned pulmonary function testing

Participants will be recruited from patients attending a planned pulmonary function clinic appointment.

They will be invited to participate when they are booking into clinic. Should they agree to participate the will have the following interventions:

1. Basic medical questionnaire
2. 2x chest band devices fitted over clothing They will then undertake their planned clinic appointment. No additional resources will be required for this.

Once they have finished their clinic appointment, the investigators will ask them to read a short script whilst recording their speech. Following this the investigators will ask them to walk 75m down the hall. The devices will then be removed and the study time is over.

Group Type EXPERIMENTAL

Respiratory monitoring band

Intervention Type OTHER

The only intervention in this study is the application of two CE marked study approved chest bands- the Go direct respiratory sensor and a biosignal respiration belt

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Respiratory monitoring band

The only intervention in this study is the application of two CE marked study approved chest bands- the Go direct respiratory sensor and a biosignal respiration belt

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Go Direct Respiration Sensor biosignal respiratory belt

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject: Human participants
* Gender: Any
* Aged 18 years and over.
* Able to give informed consent in English.
* Physically able to take part including a simple walking exercise
* Either in a asymptomatic participant group or planned for spirometry testing

Exclusion Criteria

* Significant chest deformity or having a medical device fitted in (e.g. Implantable cardioverter defibrillator (ICD), Spinal cord stimulator, Pacemaker, etc)
* Pregnant
* Unable/uncomfortable to use a chest belt device for any reason.
* Patients \<18 years old
* Unable to read and speak in English to an understandable level
* Unable to walk (aided or unaided) for 1 minute
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Southampton

OTHER

Sponsor Role collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PFT

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Mateu-Mateus, M., et al., Camera-Based Method for Respiratory Rhythm Extraction From a Lateral Perspective. IEEE Access, 2020. 8: p. 154924-154939.

Reference Type BACKGROUND

Lin, Y.-A., et al., Respiration Monitoring using a Motion Tape Chest Band and Portable Wireless Sensing Node. Journal of Commercial Biotechnology, 2022. 27.

Reference Type BACKGROUND

Ross R, Mongan WM, O'Neill P, Rasheed I, Fontecchio A, Dion G, Dandekar KR. An Adaptively Parameterized Algorithm Estimating Respiratory Rate from a Passive Wearable RFID Smart Garment. Proc COMPSAC. 2021 Jul;2021:774-784. doi: 10.1109/COMPSAC51774.2021.00110. Epub 2021 Sep 9.

Reference Type BACKGROUND
PMID: 34568878 (View on PubMed)

Vitazkova D, Foltan E, Kosnacova H, Micjan M, Donoval M, Kuzma A, Kopani M, Vavrinsky E. Advances in Respiratory Monitoring: A Comprehensive Review of Wearable and Remote Technologies. Biosensors (Basel). 2024 Feb 6;14(2):90. doi: 10.3390/bios14020090.

Reference Type BACKGROUND
PMID: 38392009 (View on PubMed)

Brochard L, Martin GS, Blanch L, Pelosi P, Belda FJ, Jubran A, Gattinoni L, Mancebo J, Ranieri VM, Richard JC, Gommers D, Vieillard-Baron A, Pesenti A, Jaber S, Stenqvist O, Vincent JL. Clinical review: Respiratory monitoring in the ICU - a consensus of 16. Crit Care. 2012 Dec 12;16(2):219. doi: 10.1186/cc11146.

Reference Type BACKGROUND
PMID: 22546221 (View on PubMed)

Pierce R. Spirometry: an essential clinical measurement. Aust Fam Physician. 2005 Jul;34(7):535-9.

Reference Type BACKGROUND
PMID: 15999163 (View on PubMed)

Flesch JD, Dine CJ. Lung volumes: measurement, clinical use, and coding. Chest. 2012 Aug;142(2):506-510. doi: 10.1378/chest.11-2964.

Reference Type BACKGROUND
PMID: 22871760 (View on PubMed)

Bhakta NR, McGowan A, Ramsey KA, Borg B, Kivastik J, Knight SL, Sylvester K, Burgos F, Swenson ER, McCarthy K, Cooper BG, Garcia-Rio F, Skloot G, McCormack M, Mottram C, Irvin CG, Steenbruggen I, Coates AL, Kaminsky DA. European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update. Eur Respir J. 2023 Oct 12;62(4):2201519. doi: 10.1183/13993003.01519-2022. Print 2023 Oct.

Reference Type BACKGROUND
PMID: 37500112 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

349993

Identifier Type: REGISTRY

Identifier Source: secondary_id

RHM CRI0461

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EMG in COPD - Factor Analysis
NCT02721199 COMPLETED